Tryptophan-2,3-Dioxygenase (TDO) deficiency is associated with subclinical neuroprotection in a mouse model of multiple sclerosis (Q37602166)

From Wikidata
Jump to navigation Jump to search
scientific article published on 24 January 2017
edit
Language Label Description Also known as
English
Tryptophan-2,3-Dioxygenase (TDO) deficiency is associated with subclinical neuroprotection in a mouse model of multiple sclerosis
scientific article published on 24 January 2017

    Statements

    Tryptophan-2,3-Dioxygenase (TDO) deficiency is associated with subclinical neuroprotection in a mouse model of multiple sclerosis (English)
    Aleksandar Stojic
    Simon Becker
    Laura-Inés Böhler
    Soumya R Mohapatra
    Günter Küblbeck
    Toshikazu Nakamura
    Hiroshi Funakoshi
    24 January 2017
    41271

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit